Asset Dedication LLC’s Moderna MRNA Stock Holding History

Asset Dedication LLC’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$42.8K	Hold	843	–	–	﹤0.01%	497
2025 Q4	$24.9K	Hold	843	–	–	﹤0.01%	625
2025 Q3	$21.8K	Sell	843 -2	-0.2%	-$56	﹤0.01%	662
2025 Q2	$23.3K	Sell	845 -268	-24%	-$7.06K	﹤0.01%	663
2025 Q1	$31.6K	Buy	1,113 +163	+17%	+$5.78K	﹤0.01%	558
2024 Q4	$39.5K	Sell	950 -68	-7%	-$3.25K	﹤0.01%	517
2024 Q3	$68K	Hold	1,018	–	–	﹤0.01%	461
2024 Q2	$121K	Buy	1,018 +300	+42%	+$38K	0.01%	380
2024 Q1	$76K	Sell	718 -50	-7%	-$5.04K	0.01%	396
2023 Q4	$77K	Hold	768	–	–	0.01%	382
2023 Q3	$79K	Buy	768 +50	+7%	+$5.58K	0.01%	386
2023 Q2	$87K	Hold	718	–	–	0.01%	384
2023 Q1	$110K	Hold	718	–	–	0.01%	353
2022 Q4	$129K	Hold	718	–	–	0.01%	341
2022 Q3	$85K	Hold	718	–	–	0.01%	357
2022 Q2	$103K	Sell	718 -40	-5%	-$5.72K	0.02%	189
2022 Q1	$131K	Hold	758	–	–	0.01%	333
2021 Q4	$192K	Sell	758 -2	-0.3%	-$585	0.02%	281
2021 Q3	$292K	Buy	760 +42	+6%	+$15.5K	0.04%	230
2021 Q2	$169K	Buy	718 +650	+956%	+$116K	0.03%	277
2021 Q1	$9K	Sell	68 -77	-53%	-$11.2K	﹤0.01%	516
2020 Q4	$15K	Buy	145 +77	+113%	+$7.79K	﹤0.01%	498
2020 Q3	$5K	Hold	68	–	–	﹤0.01%	600
2020 Q2	$4K	Buy	+68	New	+$3.72K	﹤0.01%	549

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Asset Dedication LLC's MRNA Position: Q1 2026 in Review

Asset Dedication LLC held its Moderna (MRNA) position steady in Q1 2026 at 843 shares worth $42.8K. The position accounts for ﹤0.01% of the portfolio, ranked #497.

Asset Dedication LLC first reported a position in MRNA in Q2 2020 and has held it in 24 quarters since. The position peaked at $292K in Q3 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Asset Dedication LLC held 843 shares of Moderna worth $42.8K as of Q1 2026.
Asset Dedication LLC left its Moderna share count unchanged in Q1 2026.
Moderna made up ﹤0.01% of Asset Dedication LLC's portfolio in Q1 2026, its #497 holding.
Asset Dedication LLC first reported a position in Moderna in Q2 2020 and has held it in 24 quarters since.
Asset Dedication LLC's Moderna position peaked at $292K in Q3 2021.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Asset Dedication LLC's 13F filing for Q1 2026, filed 29 May 2026.